Bispecific polypeptides and uses thereof
AssigneeCurrus Biologics Pty Ltd
InventorsMichael Kershaw, Samantha Cobb
Life of this patent
Estimating the term…
Loading patent…
AssigneeCurrus Biologics Pty Ltd
InventorsMichael Kershaw, Samantha Cobb
Estimating the term…
The present disclosure relates generally to a bispecific polypeptide, including parts and uses thereof, comprising a first binding domain, which is capable of binding an antigen presenting cell (APC) and a second binding domain, which is capable of binding to a T cell. In a first aspect disclosed herein, there is provided a bispecific polypeptide comprising a first antigen binding protein and a second antigen binding protein, the first antigen binding protein specifically binds to CD40 and wherein the second antigen binding protein specifically binds to a FLAG tag. In a second aspect disclosed herein, there is provided a bispecific polypeptide comprising a first antigen binding protein and a second antigen binding protein, wherein the first antigen binding protein specifically binds to CD206 and wherein the second antigen binding protein specifically binds to a FLAG tag.
A bispecific polypeptide comprising a first antigen binding protein and a second antigen binding protein, wherein the first antigen binding protein specifically binds to CD40 and wherein the second antigen binding protein specifically binds to a FLAG tag,
2-6. (canceled)
9-23. (canceled)
25-26. (canceled)
29-31. (canceled)
36-37. (canceled)
39-49. (canceled)
51-53. (canceled)
(canceled)
(canceled)
62-63. (canceled)
Dependencies are inferred from the claim text.